Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uri Ben-David

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Nature|January 28, 2021
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibitionYael Cohen-Sharir, James M McFarland, Mai Abdusamad, et al.
Cancer Discovery|September 9, 2024
Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid CellsMarica Rosaria Ippolito, Johanna Zerbib, Yonatan Eliezer, et al.
Nature Communications|September 9, 2024
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damageJohanna Zerbib, Marica Rosaria Ippolito, Yonatan Eliezer, et al.
Cancer Discovery|July 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical SettingChani Stossel, Maria Raitses-Gurevich, Dikla Atias, et al.
Nature|August 10, 2018
Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben-David, Benjamin Siranosian, Gavin Ha, et al.
Nature Communications|January 27, 2025
A compendium of Amplification-Related Gain Of Sensitivity genes in human cancerVeronica Rendo, Michael Schubert, Nicholas Khuu, et al.
Science (New York, N.Y.)|August 29, 2024
A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangementsSara Martin, Simone Scorzoni, Sara Cordone, et al.
Cancer Discovery|June 5, 2016
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J Aguirre, Robin M Meyers, Barbara A Weir, et al.
Transplantation|May 22, 2018
Report of the Key Opinion Leaders Meeting on Stem Cell-derived Beta CellsJon Odorico, James Markmann, Douglas Melton, et al.
Stem Cells Translational Medicine|February 28, 2015
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapiesJames A Heslop, Thomas G Hammond, Ilaria Santeramo, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Nature|January 28, 2021
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibitionYael Cohen-Sharir, James M McFarland, Mai Abdusamad, et al.
Cancer Discovery|September 9, 2024
Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid CellsMarica Rosaria Ippolito, Johanna Zerbib, Yonatan Eliezer, et al.
Nature Communications|September 9, 2024
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damageJohanna Zerbib, Marica Rosaria Ippolito, Yonatan Eliezer, et al.
Cancer Discovery|July 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical SettingChani Stossel, Maria Raitses-Gurevich, Dikla Atias, et al.
Nature|August 10, 2018
Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben-David, Benjamin Siranosian, Gavin Ha, et al.
Nature Communications|January 27, 2025
A compendium of Amplification-Related Gain Of Sensitivity genes in human cancerVeronica Rendo, Michael Schubert, Nicholas Khuu, et al.
Science (New York, N.Y.)|August 29, 2024
A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangementsSara Martin, Simone Scorzoni, Sara Cordone, et al.
Cancer Discovery|June 5, 2016
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J Aguirre, Robin M Meyers, Barbara A Weir, et al.
Transplantation|May 22, 2018
Report of the Key Opinion Leaders Meeting on Stem Cell-derived Beta CellsJon Odorico, James Markmann, Douglas Melton, et al.
Stem Cells Translational Medicine|February 28, 2015
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapiesJames A Heslop, Thomas G Hammond, Ilaria Santeramo, et al.
Pageof 8